baber/WOPTO huggingface dataset:
Patent NZ-526328-A (NZ)
Title: Steered wheel angle sensor using hydraulic flow to steering cylinder
Inventor: NELSON FREDERICK W
IPC: B62D15/02
Filed: 2003-06-06
Abstract: The apparatus consists of steering cylinder 18 with shafts 16 to steer the wheels 12A, 12B, a steering valve 20, a pump 22 and an angle sensor 28. The sensor 28 has a hydraulic motor (not shown) located in the circuit between the cylinder 18 and the valve 20 and having a power shaft (not shown), and a pair of sensors (not shown) to determine direction of rotation and hence the angular steering position of the wheels.
Patent NZ-528532-A (NZ)
Title: Production of a cycloheptapeptide containing a 5-membered heterocyclic ring as part of the cyclic peptide by a solid phase synthesis of a linear heptapeptide precursor
Inventor: ALBERICIO PALOMERA FERNANDO
IPC: C07K7/06
Filed: 2002-04-02
Abstract: Described are trunkamide A and other cycloheptapeptides made by solid phase synthesis of a linear precursor.
Patent NZ-532310-A (NZ)
Title: Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders
Inventor: KEITH CURTIS
IPC: A61K31/56
Filed: 2002-10-04
Abstract: Disclosed herein is a use of (i) a corticosteroid; and (ii) a tetra-substituted pyrimidopyrimidine of formula (I) in the preparation of a medicament for simultaneous, separate, or sequential use for treating an immunoinflainmatory disorder selected from the group consisting of rheumatoid arthritis, psoriasis, ulcerative colitis, Crohn's disease, stroke-induced brain cell death, ankylosing spondylitis, fibromyalgia, multiple sclerosis, type I diabetes, systemic lupus erythematosus, or Sjogren's syndrome, wherein the variables shown in formula (I) are as defined in the specification. Also disclosed are the corresponding pharmaceutical compositions, pharmaceutical packs and kits.
Patent NZ-533942-A (NZ)
Title: Thymalfasin can potentiate immune-mediated killing of glioblastoma cells when used as an adjuvant in combination with a chloroethylnitrosurea chemotherapeutic compound
Inventor: WANDS JACK R
IPC: A61K31/17
Filed: 2002-12-10
Abstract: Thymosin-alpha 1 is used as an adjuvant in combination with carmustine (BCNU) as an effective treatment for malignant glioblastoma. Thymalfasin enhances chloroehtylnitrosurea-mediated eradication of glioblastoma in vivo, and that thymalfasin mediates its effects by activating pro-apoptosis mechanisms, rendering neoplastic cells more sensitive to oxidative stress and killing by Granzyme B (T cells) or chemotherapy. The figure shows the effect of BCNU and BCNU + thymalfasin (THY) on glioblastoma progression in vivo.
Patent NZ-534451-A (NZ)
Title: Taste-masked film-type or wafer-type medicinal preparation
Inventor: RADEMACHER TINA
IPC: F27D21/00
Filed: 2003-02-04
Abstract: Film-shaped or wafer-shaped pharmaceutical preparation for administering active substances having an unpleasant or bitter taste is disclosed, wherein the preparation contains at least one matrix-forming polymer which has at least one active substance and at least one gas-forming component dissolved or dispersed therein, wherein the gas-forming component consists of a carbon dioxide forming substance or of a combination of such substances, and reduces or completely suppresses an unpleasant taste sensation caused by the active substance, wherein the pharmaceutical preparation is produced from a solution.
Patent NZ-534792-A (NZ)
Title: A device for actuating the valve of an aerosol container
Inventor: LAWSON TREVOR JOHN
IPC: A01M25/00
Filed: 2003-03-18
Abstract: A device which is attachable to an aerosol container (4) for actuating the valve (6) of the aerosol container, which, when combined with an electrically controllable actuator for the device, effects the discharge of gas from the aerosol container by an electrical signal. The device and actuator are especially suitable for a pest trap using a gas to kill the pest.
Patent NZ-536843-A (NZ)
Title: Device with shutter winding about a drum
Inventor: COENRAETS BENOIT
IPC: E06B9/17
Filed: 2003-06-13
Abstract: The disclosure concerns a device with a shutter co-operating with driving means for moving the shutter (1) between an opening position and a closing position, said shutter (1) being guided by a guide path (4, 5) and being designed for closing an aperture (6) or any other opening, said device comprising a drum (8) about which the shutter is wound in the latter's opening position forming a roll consisting of coils formed by several layers of the shutter (1), and from which the shutter (1) can be unwound to its closing position, wherein confinement means are provided for preventing the coils from forming creases when the shutter is being moved (1) towards its closing position and/or from sliding relative to one another.
Patent NZ-540881-A (NZ)
Title: A process for preparing enantiomerically pure N-methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine and intermediates for use therein
Inventor: RAO DHARMARAJ RAMACHANDRA
IPC: A61P25/24
Filed: 2003-12-10
Abstract: Disclosed is a process for preparing (+)duloxetine, or an acid addition salt thereof, which process comprises resolving racemic (±)duloxetine with a chiral acid so as to obtain a salt of the chiral acid and (+)duloxetine, substantially free of (-)duloxetine; and (ii) if desired, converting the salt prepared in step (i) to the free base or another acid addition salt as appropriate. The process for preparing (+)duloxetine, or an acid addition salt thereof, can further comprise an O-alkylation intermediate process step which is carried out in the presence of a base and a phase transfer catalyst.
Patent NZ-542212-A (NZ)
Title: Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive WT P53
Inventor: STROMBLAD STAFFAN
IPC: A61K31/439
Filed: 2004-03-24
Abstract: Disclosed is the use of 1-azabicyclo[2.2.2]octanes of formula (I), capable of transferring wild type p53 from an inactive and non-functional conformation into an active conformation, for the preparation of a pharmaceutical composition for use in treating medical compositions wherein wt p53 exists in an inactive state, in particular malignant melanoma and conditions involving undesired angiogenesis. Also disclosed are methods of in vivo and in vitro testing of compounds of the defined ability, wherein inactive wt p53 is monitored or detected.
Patent NZ-547043-A (NZ)
Title: Access method between marine structures and apparatus using extendable bridge on suspension wire(s)
Inventor: WATCHORN MICHAEL JOHN
Filed: 2004-11-09
Abstract: Access means are provided for accessing a fixed offshore structure such as a wind turbine (70), larger vessel or the like form a smaller transfer vessel (50), or for providing for transfer between vessels. One or more guide wires (not shown) are connected from the vessel (50) to the fixed structure (70) or second vessel and placed in tension such as by directing the transfer vessel away from the fixed structure. In one embodiment, inflatable, members are suspendable from the guide wires and inflation of the inflatable members causes them to extend along the guide wires to form an access surface (56) across which personnel may walk to access the fixed structure or second vessel from the first vessel. Mounting means are also provided which accommodate relative rotational, translational and pitching movement of the apparatus and vessel, caused by wave motion; In another embodiment, a bridge member is retained on a runway of the first vessel and deployed using said guide wires (not shown).
Patent NZ-548479-A (NZ)
Title: Shock-absorbing system for fastener driving tools using deformable members
Inventor: SHKOLNIKOV YURY
IPC: B25C1/08
Filed: 2004-12-16
Abstract: Disclosed is a combustion chamber assembly (10) for use in a combustion-powered fastener driving tool. The chamber assembly includes a cylinder body (18); a reciprocating probe assembly (26) slidably mounted to said cylinder body between a first, extended position and a second, retracted position; at least one shock-absorbing member (56), operationally associated with at least one of the cylinder body and the probe assembly for reducing shock load generated during operation of the tool. The probe assembly includes an upper probe including at least one arm portion (42) in sliding relationship relative to the cylinder body and having an upper end (44). The shock-absorbing member is disposed between the upper end and a corresponding element of the cylinder body for transmitting loads from the probe assembly to the cylinder body. The shock absorbing member is also configured to reduce load forces generated in a combustion chamber of the chamber assembly upon the probe assembly reaching the second position. The shock absorbing member is further configured and to be rigid enough to limit travel of the probe assembly relative to the cylinder body, and have sufficient resilience to absorb shock forces generated by the tool in said second position.
Patent NZ-563774-A (NZ)
Title: Inhibitors of VEGF receptor and HGF receptor signaling
Inventor: SAAVEDRA OSCAR MARIO
IPC: A61K31/4365
Filed: 2006-05-19
Abstract: The disclosure relates to a compound selected from a group thieno [2, 3b] pyridine compounds or an N-oxide, hydrate, solvate or pharmaceutically acceptable salt thereof as defined in the specification. Also disclosed is a method of inhibiting VEGF receptor signalling and HGF receptor signalling in a non-human animal, a pharmaceutical composition comprising the compound, the use of the compound in the manufacture of a medicament to inhibit VEGF receptor signalling and HGF receptor signalling, a method of inhibiting proliferative activity of an ex vivo cell comprising the compound, a method of treating a cell proliferative disease in a non-human patient, comprising administering the compound, a method of inhibiting tumour growth in a non-human patient, comprising administering the compound and the use of the compound in the manufacture of a medicament to inhibit tumour growth.
Patent NZ-564632-A (NZ)
Title: Injection appliance and method
Inventor: MARKSTEINER RAINER
IPC: A61M5/32
Filed: 2006-06-02
Abstract: An injection device 100 for injecting a substance into an organism 1 comprises a guide device 10 with a lumen 11 in which a syringe 21 is adjustably arranged, a displacement device 20 to which the syringe 21 is connected, and a holder 30 for the guide 10 and displacement devices 20. The guide 10 and displacement devices 20 are arranged on the holder 30 such that their relative position with regard to each other and to the holder 30 can be adjusted independently. This arrangement allows for more precise injection of a substance into an organism 1.
Patent NZ-565549-A (NZ)
Title: Apparatus and method for the treatment of waste
Inventor: AMES ROY VICTOR
IPC: C02F1/44
Filed: 2004-04-16
Abstract: A method of treating waste is disclosed, the method being suitable for domestic use and capable of producing water suitable for recycling within the household. The method includes use of a bioreactor (30) and a decomposition chamber (16). The bioreactor (30) is adapted to digest liquid-base waste material using bacteria and is operable under anaerobic, anoxic and/or aerobic conditions. The decomposition chamber (16) decomposes substantially solid waste generated in the bioreactor. The bioreactor and decomposition chamber are in fluid communication such that substantially solid waste material generated in the bioreactor can be transferred to the decomposition chamber for further treatment. Resulting solids may optionally be forwarded to a vegetation cell (24) and the liquid (34) leaving the bioreactor may be optionally passed to a membrane treatment unit (40) and a disinfection unit (50). A trickle bed may also be used in fluid communication with the bioreactor to control digestion conditions in the bioreactor.
Patent NZ-571433-A (NZ)
Title: Side dam assembly for a continuous caster system comprising a side dam and a side dam holder
Inventor: BOWMAN BRIAN E
IPC: B22D11/06
Filed: 2007-03-21
Abstract: A side dam assembly in a continuous twin roll caster system comprises a side dam 35 with opposite outer surfaces and a side dam holder 37. One outer surface of the side dam 35 is for contacting molten metal, and the opposite outer surface 310 has fastening portions 320, 330, 340 capable of attaching the side dam 35 to the side dam holder 37 and to hold the side dam 35 in place during casting. The side dam holder 37 has attachment portions 210, 220, 230 capable of receiving and supporting the side dam 35 at the fastening portions, without any exposed portion of the side dam holder 37 extending substantially beyond the opposite outer surface 310 of the side dam 35 toward the outer surface that contacts molten metal.
Patent NZ-572701-A (NZ)
Title: Plug and play peripheral storing driver
Inventor: HILL DOUG
IPC: G06F13/10
Filed: 2007-05-28
Abstract: An interactive input system (20) comprises a touch panel (28) having a controller (32) and a plug-and-play cable (36) connecting a computing device (40) to the touch panel and establishing a bi-directional communication channel there between. The plug-and-play cable comprises storage; executable software stored on the storage and settings stored on the controller. The software is automatically executed by the computing device when the plug-and-play cable is connected to the computing device; and the settings are transferred to the computing device via the plug-and-play cable. The settings comprise calibration settings used by the computing device to calibrate automatically the computing device and the touch panel and pen tray settings. The software enables the computing device and controller to communicate over the bi-directional communication channel and is operable to detect disconnection of the plug-and-play cable from the computing device and terminate execution in response thereto with the computing device not persistently storing the software and settings thereafter. The plug-and-play cable comprises a universal serial bus interface. The plug-and-play cable for interconnecting a touch panel having a controller and a computing device and establishing a bi-directional communication channel there between is disclosed. The plug-and-play cable comprises storage; and a hub communicating with the storage. The hub provides executable software stored on the storage to the computing device for automatic execution upon connection of the plug-and-play cable to the computing device to enable the computing device and touch panel to communicate over the bi-directional communication channel. The plug-and-play cable further communicates calibration settings and pen tray settings to the computing device when the plug-and-play cable interconnects the touch panel and computing device. The calibration settings are configured for use by the computing device to calibrate automatically the computing device and the touch panel.
Patent NZ-575482-A (NZ)
Title: Manipulation of organic acid biosynthesis and secretion with cirate synthase
Inventor: SPANGENBERG GERMAN
IPC: C12N9/10
Filed: 2004-04-14
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding citrate synthase (CS) from a Lolium species. or complementary or antisense to a sequence encoding CS from a Loilum species, said nucleic acid or nucleic acid fragment including a nucleotide sequence selected from the group consisting of: (a) sequences shown in Figures 1 and 3 hereto (SEQ ID NOs: 1 and 3 to 10 respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants having at least approximately 90% identity to the functional part of the sequences recited in (a), (b) and (c) and having a size of at least 30 nucleotides; and (e) RNA sequences corresponding to the sequences recited in (a), (b). (c) and (d). Further disclosed area substantially purified or isolated CS polypeptide from a Lolium species including an amino acid sequence selected from the group consisting of sequences shown in Figure 2 hereto (SEQ ID NO: 2) and functionally active variants thereof having at least approximately 90% identity to the recited sequences.
Patent NZ-581518-A (NZ)
Title: Generating and transmitting control channel format indicator frequency mapping
Inventor: ZHANG XIAOXIA
IPC: H04L27/26
Filed: 2008-06-20
Abstract: A method (500) for transmitting control channel information in wireless communication networks implemented by an apparatus comprising the steps of generating control channel format indicator data (502) that defines a structure of control channels subsequently transmitted over one or more antennas, selecting subcarriers of bandwidth (504) over which the control channel format indicator data is spread based at least in part on shifting subcarriers (506) utilised according to a cell identifier and transmitting the control channel format indicator data over the selected subcarriers of bandwidth (508). The subcarriers are of a first orthogonal frequency division multiplexing symbol in a given time transmit interval and include a plurality of pairs of adjacent subcarriers.
Patent NZ-585080-A (NZ)
Title: Composition comprising Vitamin B12 and N-[8-(2-hydroxybenzoyl) amino ]caprylic acid and salts thereof for treating Vitamin B12 deficiency
Inventor: CASTELLI CRISTINA
IPC: C07B43/00
Filed: 2008-10-31
Abstract: Disclosed is a pharmaceutical composition comprising vitamin B12 and at least one substance selected from the group consisting of N-[8-(2-hydroxybenzoyl) amino ]caprylic acid and pharmaceutically acceptable salts thereof. An acceptable salt is sodium N-[8-(2-hydroxybenzoyl) amino]octanoate. The composition is useful for treating vitamin B12 deficiency in a subject, in particular where the subject has failed to respond to existing vitamin B12 treatment.
Patent NZ-585891-A (NZ)
Title: Method and apparatus for measuring deposition of particulate contaminants in pulp and paper slurries
Inventor: LAURINT MARK
IPC: D21H21/02
Filed: 2008-11-26
Abstract: A method and an apparatus for measuring the depositability of particulate contaminants present in a pulp or paper mill fluid stream and evaluating interactions of such particulate contaminants with other contaminants collects the particulate contaminants on a suitable substrate, such as a plastic film coated with an adhesive or coated with. organic contaminate, placed in contact with the pulp or paper mill fluid stream for at least five minutes up to several hours. The amount of contaminants collected on the substrate is quantified and evaluated by taking one or more scanned images of the substrate with a resolution of at least 2,000 dots per inch (DPI) and analyzing the scanned images with image analysis technique.
Patent NZ-588806-A (NZ)
Title: Triphenylphosphonium based antioxidants in topical formulations for the treatment of skin conditions
Inventor: MURPHY MICHAEL PATRICK
IPC: A61K31/355
Filed: 2009-03-24
Abstract: 588806 Disclosed is the use of a topical formulation that comprises (a) an antioxidant compound of formula (Ia) which comprises a lipophilic cationic moiety linked by a linking moiety to an antioxidant moiety, and an anionic complement for said cationic moiety, or its quinol form, wherein R1, R2, and R3 are the same or different and are selected from alkyl and H; R4 is hydrogen or methyl, and wherein n is an integer from 2 to 20, and wherein Z is the anionic complement, and (b) a pharmaceutical excipient or carrier for topical use, in the manufacture of a medicament for the treatment of a skin condition that results from reactive oxygen species production in the skin of a subject, said skin condition comprising at least one of age-related skin damage, acne, skin amyloidosis, a bacterial skin infection, a fungal skin infection, a parasitic skin infection, a viral skin disease, a benign skin tumor, a skin cancer or skin damage resulting from cancer treatment, a blister, sore, skin ulcer or bullous disease, dermatitis, ichthyosis, eczema, inflammation, a hair disorder, hypersensitivity or an autoimmune disorder, an insect bite or insect sting, keratosis pilaris, pruritis, prurigo, psoriasis, pustulosis, a scaling disease, a rash, vitiligo, a sweat gland disorder, erythema, skin redness and inflammation caused by laser surgery, radiation therapy, sun burn, rosaceae, a burn or sepsis; wherein the formulation is adapted to deliver a therapeutically effective amount of the antioxidant compound to skin fibroblasts and keratinocytes and the cationic moiety is capable of mitochondrially targeting the antioxidant moiety, and wherein the anionic complement is a pharmaceutically acceptable anion that does not exhibit reactivity against the antioxidant moiety, the cationic moiety or the linking moiety; and the anionic complement is an alkyl sulfonate, or the anionic complement is an aryl sulfonate. Of particular importance is the use of the compound of formula (Ia) which is [10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl]triphenylphosphonium methanesulfonate.
Patent NZ-597324-A (NZ)
Title: Detachable pulley assembly that can quickly and easily fastened to an exercise assembly
Inventor: ENDELMAN KEN
IPC: A63B21/00
Filed: 2010-07-01
Abstract: A pulley assembly 200 for removably fastening an arm cord to an exercise apparatus is disclosed. The pulley assembly 200 includes a yoke 202 having a central portion and a pair of parallel leg portions, the central portion having a bore therethrough, a pulley wheel 204 rotatably supported between the yoke 202 leg portions by an axle, and an elongated stem 208 having an axially extending shaft portion protruding through the bore. The shaft portion has distal end portion having an L shaped slot formed therethrough. The L shaped slot forms a hook shaped end to the shaft portion. A tapered coil spring 222 over the shaft portion of the stem 208, has a small end and a large diameter around the shaft portion of the stem 208. The spring 222 biases the hooked end away from an eyebolt on the exercise apparatus to keep the pulley assembly 200 engaged with the eye bolt and hence fastened to the exercise apparatus.
Patent NZ-597793-A (NZ)
Title: Process for the identification of compounds for treating cancer
Inventor: SOENGAS GONZALEZ MARIA SOLEDAD
IPC: A61K48/00
Filed: 2010-07-05
Abstract: 597793 PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER Provided is a process for the identification of compounds to be used as therapeutic agents for treating cancer comprising the steps of: a) Contacting the candidate compound with a cancer cell culture, or cancer cell line derived from cancer cells; b) Determining the level of activation of a family helicase MDA-5 or the level of NOXA expression, in combination with the determination of the induction of autophagy in cancer cells or in a cell line derived from cancer cells; c) Comparing the data obtained in step b) with those observed in control of the same cells treated similarly, but in the absence of the candidate compound; d) Selecting the compounds which have given rise to a significant increase in the parameter or parameters determined in step b) in comparison with the control. Further provided is an autophagy inducing compound by way of the length of the at least 1000 nucleotides long polyinosine-polycytidylic acid (pIC) combined with polyethyleneimine (PEI).
Patent NZ-599839-A (NZ)
Title: Synergistic antiviral composition and use thereof
Inventor: GRASSAUER ANDREAS
IPC: A61K31/13
Filed: 2010-12-17
Abstract: 599839 The disclosure relates to iota- and/or kappa-carrageenan in combination with a neuraminidase inhibitor for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection by an influenza virus. Said neuraminidase inhibitor is selected from the group consisting of zanamivir, oseltamivir, peramivir and laninamivir. Particularly the invention provides for treatment beginning after 2 days from first presenting symptoms.